Vestjysk Bank A/S
Nasdaq Copenhagen A/S
26 February 2021
The Board of Directors of Vestjysk Bank A/S hereby gives notice of the annual general meeting. The annual general meeting will be held on Monday 22 March 2021 at 3.00 p.m. The annual general meeting will be held electronically without the possibility of physical attendance.
The agenda is as follows:
- The Board of Directors' oral report on the activities of the Bank during the past year
- Presentation and adoption of the audited annual report
- Resolution on the distribution of the profit or loss recorded in the annual report adopted by the general meeting
- Presentation of the remuneration report for an advisory vote
- Approval of remuneration to the Board of Directors in the current financial year
- Election of members of the Board of Directors, including the chairman and the vice-chairman
- Election of auditor
- Proposals from the Board of Directors
- Proposal to grant authorisation to the chairman of the meeting
- Any other business
Vestjysk Bank A/S
The Board of Directors
Attachments
- Schedule 1 - Notice of annual general meeting 2021 including the full text of the proposals
- Schedule 2 - Guidance on electronic annual general meetings
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Wolters Kluwer N.V.9.1.2026 20:38:32 CET | Press release
Wolters Kluwer acquires StandardFusion
AACSB International9.1.2026 20:36:10 CET | Press release
AACSB Opens Public Comment on 2026 Global Standards for Business Education
Aspo Plc9.1.2026 17:30:00 CET | Press release
Aspo Plc: Share repurchase 9.1.2026
Aalborg Boldspilklub A/S9.1.2026 16:48:49 CET | Pressemeddelelse
Foreslået ændring i bestyrelsen i AaB A/S
Novartis Pharma AG9.1.2026 16:30:00 CET | Press release
Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
